Pharma Tech Outlook Names LinkChem as Top 10 CROs in APAC 2022

LinkChem is honored to announce that the internationally renowned pharmaceutical magazine "Pharma Tech Outlook", awarded LinkChem among the Top 10 CROs in Asia and the Pacific recently. The award aims to recognize developing CRO companies in the Asia-Pacific region of the pharmaceutical industry. LinkChem was recognized in the five values of "quality of services, experience, capabilities, communication, and service cost" through the comprehensive analysis of data collected from the pharmaceutical industry.

As a global pharmaceutical CRO and CDMO service provider, LinkChem is committed to serving global research institutions and innovative drugs companies with rigorous technology development and continuous innovation for many years, with the advantages of professionalization, formalization, and platformization. LinkChem will continue to take the research, development, and industrialization as the company's overall and long-term development strategy, aimed at actively contributing to the cause of life, health, and green energy innovation.

https://www.pharmatechoutlook.com/linkchem

Pharma Tech Outlook is a leading monthly publication that provides a knowledge network for scaling pharma technology transformation and brings forth real-world solutions, news, and product trends in the pharmaceutical industry. The magazine has contributors from the most established organizations and reaches over 76,000 subscribers in the Asia-Pacific region.